Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |